SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178253-15-000034
Filing Date
2015-03-30
Accepted
2015-03-30 09:09:32
Documents
21
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scyx-20141231x10k.htm 10-K 2708315
2 EXHIBIT 10.27 exhibit1027employmentagree.htm EX-10.27 142679
3 EXHIBIT 10.29 exhibit1029-merialrsa.htm EX-10.29 159587
4 EXHIBIT 10.32 exhibit1032-waterstone.htm EX-10.32 229704
5 EXHIBIT 10.33 exhibit1033-merckletter.htm EX-10.33 8042
6 EXHIBIT 23.1 exhibit231-consentletter.htm EX-23.1 2106
7 EXHIBIT 31.1 annual2014exhibit311.htm EX-31.1 8523
8 EXHIBIT 31.2 annual2014exhibit312.htm EX-31.2 8631
9 EXHIBIT 32.1 annual2014exhibit321.htm EX-32.1 9143
16 capture1.jpg GRAPHIC 29084
17 capture2.jpg GRAPHIC 30886
18 capture3.jpg GRAPHIC 28405
19 fulldevelopmentprocesschart.jpg GRAPHIC 162413
20 overviewimage.jpg GRAPHIC 26307
21 phase2detailedtable.jpg GRAPHIC 111027
  Complete submission text file 0001178253-15-000034.txt   15707350

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT scyx-20141231.xml EX-101.INS 1888795
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT scyx-20141231.xsd EX-101.SCH 90882
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT scyx-20141231_cal.xml EX-101.CAL 112599
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT scyx-20141231_def.xml EX-101.DEF 408087
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT scyx-20141231_lab.xml EX-101.LAB 1047616
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT scyx-20141231_pre.xml EX-101.PRE 657248
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36365 | Film No.: 15732616
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences